1. Home
  2. OLPX vs NBTX Comparison

OLPX vs NBTX Comparison

Compare OLPX & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Olaplex Holdings Inc.

OLPX

Olaplex Holdings Inc.

HOLD

Current Price

$2.04

Market Cap

1.0B

ML Signal

HOLD

Logo Nanobiotix S.A.

NBTX

Nanobiotix S.A.

HOLD

Current Price

$31.00

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OLPX
NBTX
Founded
2014
2003
Country
United States
France
Employees
N/A
N/A
Industry
Package Goods/Cosmetics
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.0B
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
OLPX
NBTX
Price
$2.04
$31.00
Analyst Decision
Buy
Strong Buy
Analyst Count
4
1
Target Price
$1.89
$36.00
AVG Volume (30 Days)
3.7M
41.8K
Earning Date
05-05-2026
03-31-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$422,960,000.00
N/A
Revenue This Year
$2.95
$58.17
Revenue Next Year
$3.39
N/A
P/E Ratio
N/A
N/A
Revenue Growth
0.07
N/A
52 Week Low
$0.99
$3.30
52 Week High
$2.04
$41.89

Technical Indicators

Market Signals
Indicator
OLPX
NBTX
Relative Strength Index (RSI) 68.10 46.22
Support Level $2.02 $29.30
Resistance Level $2.04 $34.66
Average True Range (ATR) 0.01 1.50
MACD -0.02 -0.04
Stochastic Oscillator 75.00 13.79

Price Performance

Historical Comparison
OLPX
NBTX

About OLPX Olaplex Holdings Inc.

Olaplex Holdings Inc is a science-enabled, technology-driven beauty company. It offers science-backed solutions that improve hair health. It identifies the majority of consumers' relevant haircare concerns in collaboration with the community of professional hairstylists and consumers and strives to address them through its proprietary technology and innovation capabilities. It offers products through an omnichannel platform that serves professional, specialty retail, and DTC channels. The company derives its revenue through the sale of its hair care products. The company generates the majority of revenue from Professional sales channels followed by Specialty Retail and then DTC. Geographically the company generates the majority of its revenue from the International market.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

Share on Social Networks: